Alnylam Pharmaceuticals
ALNY
#871
Rank
NZ$49.57 B
Marketcap
NZ$370.49
Share price
-0.55%
Change (1 day)
-49.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company